Stay updated on Gantenerumab in Mild Alzheimer Disease Clinical Trial

Sign up to get notified when there's something new on the Gantenerumab in Mild Alzheimer Disease Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Gantenerumab in Mild Alzheimer Disease Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.5.3 to v3.5.4, indicating a minor update to the site; the study details and navigation remain unchanged.
    Difference
    0.0%
    Check dated 2026-05-17T05:26:48.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The Malmö, Sweden entry replaces Malmo, Sweden, 211 46 to reflect the proper Swedish spelling in the study locations.
    Difference
    0.0%
    Check dated 2026-05-02T22:56:42.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The page’s displayed software/version revision indicator was updated from v3.5.2 to v3.5.3.
    Difference
    0.0%
    Check dated 2026-04-25T16:49:31.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2. Deleted Revision: v3.5.0.
    Difference
    0.0%
    Check dated 2026-04-18T13:02:14.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    Revision: v3.5.0 added; v3.4.3 removed.
    Difference
    0.0%
    Check dated 2026-03-20T19:48:59.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-06T18:24:41.000Z thumbnail image

Stay in the know with updates to Gantenerumab in Mild Alzheimer Disease Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Gantenerumab in Mild Alzheimer Disease Clinical Trial page.